WHO strategic action plan on antibiotic resista ance in Europe Strengthening g surveillance Dr Danilo Lo Fo Wong Senior Adv viser AMR
Backg ground AMR costs money, livelihoods and lives, and undermines healthh programmes World Health Assembly resolutions in 1984,1998, 2001, 2005 WHO global strategy for containment of AMR published in 2001 Despite progress, strategies widely implemented for AMR containment not
WHD 201 11 slogan
World Healt th Day 2011 Toolkit for Health Ministers, stakeholders & partners: Policy Package background paper Policy Briefs Events and Press briefings Press kit (incl. news release, sta photos, videos) atement,
Cornerstones of strategic direction I. Surveillance - to document the problem II. Prevention - to slow the emergence of HAI and AMR III. Containment - to reduce the spread IV. Research & Innovation - to develop new tools, new drugs & guidelines Multi-dimensional aspects - multisectoral, interdisciplinary
European strategic action plan on European strategic action plan on antibiotic resistance 2011 2016 2011 2016 Dr Guenael Rodier Dr Guenael Rodier Director, Division of Communicable Diseases, Health Security Director, Division of Communicable and Environment Diseases, Health Security and Environment
Regional Comm mittee for Europe Resolution, Baku, Azer rbaijan, 12-15 September 2011 Member States Ensure political commitment and resources for developing and implementing national plans Strengthen surveillance and monitoring of antibiotic resistance and consumption Establish multisectoral and comprehensive coordination and cooperation mechanisms Adhere to infection control Raise awareness through national campaigns
Regional Comm mittee for Europe Resolution, Baku, Azer rbaijan, 12-15 September 2011 WHO Regional Office for Europe Provide strategic leadership, guidance and tools for implementing the strategic action plan Support Member States in im mplementing national plans Create platforms for sharing experience and analysing data and Engage in broad regional and global partnerships Promote innovation and research
Action Plan Stra ategic Objectives 1. Strengthen intersectoral coordination Comprehensive national action plans Multisectoral and interdisciplinary national coordination mechanisms 2. Strengthen surveillance of antibiotic resistance National surveillance systems, collecting, analysing and reporting data to monitor trends Regional databases, tools and standards 3. Promote rational use of antibiotics and strengthen surveillance National mechanisms for coordination National guidelines on prudent use of antibiotics Surveillance of antibiotic consumption 4. Strengthen infection control and surveillance in health care settings Prevention of hospital-acquired infections Hospital infection control and surveillance committees
Action Plan Stra ategic Objectives 5. Prevent emerging resistance in veterinary and food sectors Prudent use of antibiotics in these sectors Integrated systems for surveillance of antibiotic resistance and use 6. Promote innovation and research on new drugs International surveillance networks and information sharing on promising research areas Active role in research for governments and academic network ks; national and international task forces 7. Improve awareness, patient safety, and partnership Educational initiatives, behaviour change campaigns and awareness programmes for health care providers and the public Broad partnership at national, regional and global levels
Considerations fo or implementation and mon nitoring Strategic action plan with: time frame for implementation estimated resource needs input, process and output indicators to monitor progress Stepwise approach: mapping of available data, identification of current practices Support to Member States in: developing and implementing national action plans establishing national coordinating mechanisms
Cycle of (Veterina ary) Public Health Prote ection Surveillance Risk management Epidemiological evaluation Risk assessment Research
AMR Surv veillance Needed to: Detect resistant strains of public health importance Support prompt notification and investigation of outbreaks Inform clinical treatment decisions Guide policy recommendations Monitor efficacy of interventions (incl. infection control measures)
European Antimicrobial Resi istance Surveillance Network
Antimicrobial Use Monitoring Needed to: Track use, overuse and misuse of antimicrobials Provide insights to assess th he public health consequences
European Surveillan nce of Antimicrobial Consumpti ion (ESAC) http://app.esac.ua.ac.be/public/ ESAC is a project funded by ECDC
Strengthening g surveillance Focus on non-eu Member States Promote national committees and action plans Gradually set up a surveillance network compatible with EARS-Net and ESAC-Net Close coordination with EC and ECDC Collaboration with strong technical partners
WHO Collaborating Centres (Europe) WHO CC for Reference & Research on Hospital Infections Health Protection Agency, London, United Kingdom WHO CC on Patient Safety University of Geneva Hospitals - Geneva, Switzerland WHO CC for Antimicrobial Resist tance in Foodborne Pathogens National Food Institute, Copenhagen, Denmark WHO CC for Research and Training in Surveillance of Communicable Diseases and Antimicrobial Resistance National Centre for Infectious and Parasitic Diseases, Sofia, Bulgaria WHO CC for Drug Statistics Methodology Norwegian Institute of Public Health - Oslo, Norway
Partn ners ECDC DG SANCO/ DG Research RIVM (National Institute for Public Health a ESCMID (European Society of Clinical Mic HPA (UK Health Protection Agency) EMA (European Medicines Agency) EFSA (European Food Safety Authority) CDC (Centers for Disease Control and Pre and many more and the Environment ) crobiology and Infectious Diseases) evention, United States of America)
Thank you for your attention